Introduction. Soft tissue sarcomas are a heterogeneous group of malignant tumors derived from the embryonic mesenchymal and neuroectodermal tissue. In Poland, they constitute about 7% of all childhood malignant tumors and represent the fifth group of the most common tumorous under the age of 16 after leukemia, central nervous system tumor, lymphoma and neuroblastoma. When starting treatment of a child with cancer, the following points should be taken into account: the type, localization and size of cancer with its dynamics and the stage of disease, the general condition and the age of a patient. The contemporary treatment of patients with malignant tumor is combined and multi-profile. This treatment consists of multidrug chemotherapy, surge...
Soft tissue sarcomas are rare malignancies originating from mesenchymal origin. They may occur at an...
Diana A Steppan, Christine A Pratilas, David M Loeb Division of Pediatric Oncology, The Sidney Kimme...
Section editors Laurence Baker and Jaap Verweij have disclosed no financial relationships relevant t...
PurposeSynovial sarcoma (SS) is the second most common malignant soft tissue tumor in children. ARST...
BACKGROUND: To report the results of the first European prospective nonrandomized trial dedicated to...
Abstract BACKGROUND Survivors of childhood malignancies have an increased risk of developing second...
To report the results of the first European prospective nonrandomized trial dedicated to pediatric s...
: Synovial sarcoma (SS) is a rare and aggressive disease that accounts for 5%-10% of all soft tissue...
International audienceSoft tissue sarcomas in children are rare tumor, representing around 6 to 7% o...
This paper describes the standard of care for patients with non-rhabdomyosarcoma soft tissue sarcoma...
cords and pathologic findings of 37 children and adoles-cents with synovial sarcoma treated at our i...
The current article focuses on non-rhabdomyosarcoma soft tissue sarcoma (NRSTS), the heterogeneous g...
Synovial sarcoma is malignant soft tissue tumor which is the most prevalent in adolescents and young...
Synovial sarcoma (SS) is an aggressive soft-tissue tumor noted for late local recurrence and metasta...
Introduction: Synovial sarcoma (SS) is uncommon high grade soft tissue sarcoma, accounting for less ...
Soft tissue sarcomas are rare malignancies originating from mesenchymal origin. They may occur at an...
Diana A Steppan, Christine A Pratilas, David M Loeb Division of Pediatric Oncology, The Sidney Kimme...
Section editors Laurence Baker and Jaap Verweij have disclosed no financial relationships relevant t...
PurposeSynovial sarcoma (SS) is the second most common malignant soft tissue tumor in children. ARST...
BACKGROUND: To report the results of the first European prospective nonrandomized trial dedicated to...
Abstract BACKGROUND Survivors of childhood malignancies have an increased risk of developing second...
To report the results of the first European prospective nonrandomized trial dedicated to pediatric s...
: Synovial sarcoma (SS) is a rare and aggressive disease that accounts for 5%-10% of all soft tissue...
International audienceSoft tissue sarcomas in children are rare tumor, representing around 6 to 7% o...
This paper describes the standard of care for patients with non-rhabdomyosarcoma soft tissue sarcoma...
cords and pathologic findings of 37 children and adoles-cents with synovial sarcoma treated at our i...
The current article focuses on non-rhabdomyosarcoma soft tissue sarcoma (NRSTS), the heterogeneous g...
Synovial sarcoma is malignant soft tissue tumor which is the most prevalent in adolescents and young...
Synovial sarcoma (SS) is an aggressive soft-tissue tumor noted for late local recurrence and metasta...
Introduction: Synovial sarcoma (SS) is uncommon high grade soft tissue sarcoma, accounting for less ...
Soft tissue sarcomas are rare malignancies originating from mesenchymal origin. They may occur at an...
Diana A Steppan, Christine A Pratilas, David M Loeb Division of Pediatric Oncology, The Sidney Kimme...
Section editors Laurence Baker and Jaap Verweij have disclosed no financial relationships relevant t...